Compare LUNG & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | BOF |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 49.6M |
| IPO Year | 2020 | 2023 |
| Metric | LUNG | BOF |
|---|---|---|
| Price | $1.46 | $4.50 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 598.0K | 86.1K |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.64 | ★ 31.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,497,000.00 | $3,184,018.00 |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.01 | ★ 258.20 |
| 52 Week Low | $1.13 | $1.93 |
| 52 Week High | $3.88 | $5.25 |
| Indicator | LUNG | BOF |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 54.75 |
| Support Level | $1.39 | $3.00 |
| Resistance Level | $1.67 | $4.86 |
| Average True Range (ATR) | 0.12 | 0.44 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 70.31 | 50.86 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.